...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >Tanshinol Alleviates Osteoporosis and Myopathy in Glucocorticoid-Treated Rats
【24h】

Tanshinol Alleviates Osteoporosis and Myopathy in Glucocorticoid-Treated Rats

机译:丹参醇缓解糖皮质激素治疗的大鼠骨质疏松症和肌病

获取原文
获取原文并翻译 | 示例
           

摘要

Tanshinol is a major water-soluble active component of Salvia miltiorrhiza . In this study, we aimed to investigate whether tanshinol has potential therapeutic effects against glucocorticoid-induced osteoporosis and glucocorticoid-induced myopathy. Ninety-six female Sprague-Dawley rats were randomly assigned to five groups: a control group, a model group, and three model groups treated with 25 or 50 mg/kg of tanshinol, or calcitriol. All model groups received prednisone acetate for 90 days to induce glucocorticoid-induced osteoporosis. Afterwards, all animals underwent a surgical procedure to induce bone defects at the right proximal tibia. Prednisone treatment was stopped after surgery, but tanshinol or calcitriol treatment was continued to the endpoint. At the experimental endpoint, compared to the model group, 25 mg/kg tanshinol could significantly reverse glucocorticoid-induced loss of bone mineral density by 12.5 %, while enhancing mechanical bone strength, causing a significant 11 % increase in trabecular number, and reducing trabecular separation by 28 %. In addition, tanshinol improved the bone microarchitecture and prevented glucocorticoid-induced bone loss by promoting bone formation and inhibiting bone resorption. Moreover, results of bone defect repair and muscle weight measurements revealed that tanshinol accelerated the bone fracture healing process and attenuated muscle atrophy caused by glucocorticoid. Furthermore, qRT-PCR analysis showed a 1-fold upregulation in mRNA levels of transforming growth factor beta and roughly 6-fold increases in vascular endothelial growth factor mRNA expression in calluses from the tanshinol groups. Tanshinol also preserved muscular ubiquitin mRNA levels from glucocorticoid-induced elevation. These findings demonstrate the potential benefits of tanshinol against glucocorticoid-induced osteoporosis and glucocorticoid-induced myopathy, which warrants further investigation in future studies.
机译:丹参醇是丹参的主要水溶性活性成分。在这项研究中,我们旨在调查丹参醇是否对糖皮质激素诱导的骨质疏松症和糖皮质激素诱导的肌病具有潜在的治疗效果。九十六六个雌性Sprague-Dawley大鼠随机分配到五组:对照组,模型组和用25或50mg / kg丹石或钙质治疗的三种模型组。所有模型组接受泼尼松醋酸盐90天以诱导糖皮质激素诱导的骨质疏松症。之后,所有动物都经历了外科手术,以诱导右侧胫骨的骨缺损。手术后停止泼尼松治疗,但继续丹皮尔或钙质处理终点。在实验终点,与模型组相比,25mg / kg丹林可以显着反向糖皮质激素诱导的骨髓矿物质密度损失12.5%,同时提高机械骨强度,导致小梁数增加11%,并减少了毛线术分离28%。此外,丹参醇通过促进骨形成和抑制骨吸收来改善骨微体系结构并防止糖皮质激素诱导的骨质损失。此外,骨缺损修复和肌肉重量测量结果显示丹参醇加速了糖皮质激素引起的骨折愈合过程和减毒肌萎缩。此外,QRT-PCR分析显示在转化生长因子β的mRNA水平中的1倍上调,并且在丹参醇基团的愈伤组织中血管内皮生长因子mRNA表达大致6倍。丹参醇还从糖皮质激素诱导的升高中保存了肌肉泛素mRNA水平。这些研究结果表明丹参醇对糖皮质激素诱导的骨质疏松症和糖皮质激素诱导的肌病的潜在益处,这是在未来的研究中进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号